Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel vs Paclitaxel in First-Line HER2-Negative Metastatic Breast Cancer
NCT03048942Phase 2Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Dec 2014
- Primary completion
- Apr 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in breast cancer, sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Started Dec 2014; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03048942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03048942.